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ABSTRACT  
Magnesium (Mg2+) homeostasis is critical for metabolism. The genetic determinants of the 
renal handling of Mg2+, which is crucial for Mg2+ homeostasis, and their potential influence 
on metabolic traits in the general population are unknown. Plasma and urine parameters were 
obtained of 9,099 individuals from 7 cohorts for the first genome-wide meta-analysis of Mg2+ 
homeostasis. Two novel loci, TRPM6 (rs3824347, P = 4.4×10-13) and ARL15 (rs35929, P = 
2.1×10-11), for urinary Mg2+ (uMg) were identified, accounting together for 2.3% of the 
variation in 24-h uMg excretion. In human kidney cells, ARL15 was shown to regulate 
TRPM6-mediated currents. In zebrafish, the expression of the highly conserved ARL15 
orthologue, arl15b, was regulated by dietary Mg2+ and arl15b-knockdown resulted in renal 
Mg2+ wasting and metabolic disturbances. The association of uMg with fasting insulin and fat 
mass was modified by ARL15 rs35929 in a general population. The combined observational 
and experimental approach uncovers a novel gene-environment interaction linking Mg2+ 
deficiency to insulin resistance and obesity.  
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INTRODUCTION 
Magnesium (Mg2+) is an essential cation for multiple enzymatic reactions, including those 
involving DNA and protein synthesis and energy metabolism 1. Abnormal Mg2+ levels in 
serum are associated with common diseases such as diabetes and metabolic disorders 2. 
Interventional and longitudinal observational studies in humans show that high dietary Mg2+ 
protects against the risk of developing type 2 diabetes 3-6 and improves glycemic control in 
diabetic patients 7 as well as in overweight non-diabetic subjects 8-10. In young adults, high 
Mg2+ intake is significantly associated with lower incidence of metabolic syndrome 11. 
Furthermore, there is evidence linking Mg2+ intake to body weight regulation, with low 
intake potentially impairing lean body mass growth 12, 13, whereas Mg2+ supplementation may 
increase lean body mass and decrease fat mass in overweight women 14. 
 Plasma Mg2+ levels are closely regulated and remain constant throughout life, despite 
the fact that dietary Mg2+ intake and intestinal absorption decrease with age 15. The control of 
Mg2+ balance is ensured by a tightly regulated reabsorption of Mg2+ in the distal tubular 
segments of the kidney. In particular, the Mg2+ filtered in the glomerulus is reabsorbed in the 
proximal tubule and thick ascending loop of Henle (TAL) via paracellular routes, while 
downstream, in the distal convoluted tubule (DCT), Mg2+ is efficiently reabsorbed through  
transcellular mechanisms involving the transient receptor potential cation channel, subfamily 
M, member 6 (TRPM6) 2. The reabsorption of Mg2+ in the DCT determines the final urinary 
Mg2+ (uMg) excretion since no reabsorption of Mg2+ occurs in posterior segments. Subjects 
harboring inherited or acquired dysfunctions of the renal tubular handling of Mg2+ show 
inappropriate urinary loss of Mg2+ causing chronic hypomagnesemia and severe, multi-
systemic manifestations 2, 16, 17.  
 The genetic component of Mg2+ homeostasis is indicated by a significant heritability 
(15-39%) of serum Mg2+ 18, 19 and by rare monogenic disorders disturbing renal tubular 
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transport of Mg2+ 20-23. Yet, most of the regulatory genes of renal Mg2+ channels and 
transporters remain unknown. A genome-wide association study (GWAS) on serum Mg2+ in 
European ancestry adults identified six loci, one of which included the gene encoding 
TRPM6 24. Two more recent studies in children 25 and in African-Americans 26 did not reveal 
additional loci. However, changes in uMg excretion precede changes in circulating serum 
Mg2+ levels, being thus a more sensitive indicator of any disturbance in Mg2+ homeostasis 27. 
Furthermore, Mg2+ depletion can be found in individuals with apparently normal total serum 
Mg2+ levels 28, which underscores the limitations of total serum Mg2+ as a marker of Mg2+ 
status. Assessment of uMg in GWAS is therefore crucial to elucidate new genes involved in 
Mg2+ homeostasis. Furthermore, studying the association between the genetic determinants of 
uMg and metabolic phenotypes linked to disturbed Mg2+ balance (e.g. obesity and diabetes) 
may provide novel insights on links between Mg2+ and common diseases. Indeed, plasma 
triglycerides and glucose are major determinants of the Mg2+ balance in diabetic patients 29. 
 In order to shed light on the genetic factors and molecular mechanisms linking Mg2+ 
handling and metabolic disorders, we performed a meta-analysis of GWAS for the renal 
handling of Mg2+ by combining genetic isolates and population-based studies and 
investigating the biological relevance of the identified loci using cellular systems and model 
organisms. Given the known relationships of Mg2+ intake with metabolic disorders, we also 
explored whether the identified loci modified these relationships. These studies establish a 
novel biological control of renal Mg2+ handling, and a novel gene-environment interaction 
sustaining the link between Mg2+ homeostasis, insulin resistance and obesity.  
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RESULTS  
Meta-analyses of GWAS for magnesium homeostasis  
The initial discovery phase consisted of a GWAS (2.5 M markers) performed on the 
population-based CoLaus cohort (5,150 samples) testing for association with uMg-to-
creatinine ratio. The analysis revealed a single genome wide significant signal at rs3824347 
(P = 3.6×10-8), corresponding to the TRPM6 locus on chromosome 9, and six suggestive loci 
with P values below 10-5 (Suppl. Fig. 1). These association results were combined with the 
genome-wide association scans from six additional European cohorts (LBC1936, CROATIA-
Split, CROATIA-Vis, Carlantino, CROATIA-Korcula, and Val Borbera) into a single meta-
analysis (9,099 samples). As shown on the Manhattan plot (Fig. 1a), two signals showed a P 
value below 5×10-8. The QQ plot showed no problematic inflation (λ=1.014, se=3.16x10-5) 
(Suppl. Fig. 2a). Both the forest plots (Fig. 1b) and the low I-square values (Table 1) 
indicated little heterogeneity across cohorts. No secondary signals were detected in the 
approximate conditional analysis using the lead single nucleotide polymorphisms (SNPs) as 
covariates in the regression (Suppl. Fig 2b and 2c). The lowest combined P value (4.4×10-13) 
was observed for the SNP rs3824347 on chromosome 9, at a locus comprising five genes, 
TRPM6, C9orf40, C9orf41, NMRK1 and OSTF1 (Fig. 1c). The second strongest signal maps 
to chromosome 5 with a P value of 2.1×10-11 for the lead SNP rs35929 (Fig. 1d). This SNP 
and all other genome-wide significant SNPs at this locus lie in the first intron of the ADP 
ribosylation factor like GTPase 15 (ARL15) gene. None of the two signals showed significant 
association with urinary creatinine.  
 Results from the versatile gene-based association study (VEGAS analysis) 30 of 
uMg/creatinine ratio identified C9orf40, C9orf41 and TRPM6 as the only genes with a 
statistically significant result (P < 2.8×10−6), however these signals are overlapping with the 
single SNP association in the meta-analysis (rs3824347). None of the discovered SNPs tag 
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copy number variations (CNVs). A pathway analysis has been performed using the Magenta 
algorithm, but no enrichment appeared to be significant after multiple testing correction. Sex-
stratified analyses did not reveal additional genome-wide significant loci. No significant 
eQTL is referenced for rs35929 nor rs3824347 in the GTEx portal.  
 A meta-GWAS of serum Mg2+ levels replicated the previously published locus on 
chromosome 1 24 containing among many others the gene MUC1 (P = 4.45×10-14) (Suppl. 
Table 1, Suppl. Fig. 3). Our meta-analysis on fractional excretion of Mg2+ (FEMg) yielded 12 
suggestive loci with a P < 10-5 (Suppl. Fig. 4) but no genome-wide significant association 
(the sample size was reduced to cohorts having serum and urine from the same time point, 
therefore without LBC1936, Split and Vis; n = 7,976). The association of rs35929 (P = 
2.8x10-4) and rs3824347 (P = 1.4x10-5) with FEMg were nominally, but not genome-wide, 
significant. 
 
A genetic score including rs35929 and rs3824347 associates with uMg traits 
Urinary Mg-to-creatinine ratio (Fig. 2a, CoLaus cohort), FEMg in spot urine (Fig. 2b, 
CoLaus cohort) and uMg excretion in 24-h urine (Fig. 2c, Swiss Kidney Project on Genes in 
Hypertension (SKIPOGH) cohort), but not serum Mg2+ (Fig. 2d, CoLaus), were strongly and 
linearly associated with an additive unweighted genetic risk score including rs35929-A 
(ARL15) and rs3824347-G (TRPM6) alleles. The genetic score explained 2.3% of 24-h uMg 
excretion in the SKIPOGH study and 1.0% of uMg-to-creatinine ratio in CoLaus. 
 
ARL15 regulates TRPM6 channel activity 
To validate the association between uMg excretion and ARL15 and TRPM6 variants, we first 
showed that the highest mRNA expression of Arl15 was in distal nephron segments including 
the TAL and DCT, the DCT being also strongly positive for Trpm6 (Fig. 3a). At protein 
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level, ARL15 is localized predominantly in the TAL and the DCT segments (Fig. 3b), which 
are enriched in Tamm-Horsfall (TH) protein and the Na+-Cl--co-transporter (NCC) 
respectively. Importantly, TRPM6 is also distinctly localized in the DCT segment 31. The 
spatial correlation between TRPM6 and ARL15 expression in the DCT prompted us to 
postulate a functional interaction between these two proteins. In addition, functional protein 
association network analyses for ARL15 (Suppl. Fig. 5) showed that ARL15 interacts with 
key proteins for endocytic trafficking (RAB11 and ARFGEF families), a process that may 
increase the abundance and channel activity of TRPM6 in the plasma membrane. 
 To assess the potential effect of ARL15 on TRPM6 channel activity, human 
embryonic kidney 293 (HEK293) cells were transfected with wild type (WT) TRPM6 in 
parallel with a mock transfect, WT ARL15 or a dominant negative (T46N) ARL15 mutant. 
The T46N ARL15 mutant was predicted to be of dominant negative nature by comparative 
analysis with T27N ARF6, a dominant negative mutant affecting a protein (ARF6) that 
belongs to the same protein family as ARL15 32. Patch clamp recordings showed 
characteristic slowly developing outwardly-rectifying currents in all conditions (Fig. 3c-f). A 
significant increase in TRPM6 channel activity was observed in the presence of WT ARL15, 
but not with the T46N ARL15 mutant (Fig. 3e). HEK293 cells express endogenous TRPM7 
channels 33. Here, these currents were small (< 50 pA/pF) and were not significantly 
increased by expression of WT ARL15 (Fig. 3f).  
 
Physiological relevance of ARL15 in model organisms 
To support the important role of ARL15 in Mg2+ homeostasis, we investigated the regulation 
of TRPM6 and ARL15 gene expression in mice upon exposure to variable Mg2+ diets, known 
to affect the expression of critical genes in the mouse kidney and intestine 34, where Arl15 is 
expressed (Suppl. Fig. 6a). Metabolic profiling (Suppl. Tables 6-7) revealed a remarkable 
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adaptation after exposure to high and low Mg2+ diets, reflected by significant changes in the 
renal mRNA expression of Trpm6 and parvalbumin (Pvalb), contrasting with the stable 
expression of Arl15 and other segmental markers of the TAL and DCT (Suppl. Fig. 6b). A 
similar effect was observed in the ileum and the caecum, also involved in Mg2+ handling 2, 34 
(Suppl. Fig. 6c-d). 
 We further tested the biological relevance of ARL15 by using a zebrafish model, 
which shows tubular segmentation patterns that are equivalent to the mammalian kidney 35.  
Two distinct orthologs of mammalian ARL15 were identified in zebrafish: arl15a and 
arl15b, presenting  68% and 83% of AA identity respectively when aligned to the human 
counterpart (Suppl. Fig. 7a). Given the higher AA conservation of arl15b compared to 
arl15a, arl15b was selected to study the function of its mammalian ortholog ARL15. As 
mammalian ARL15, arl15b was ubiquitously expressed in all adult zebrafish tissues tested 
(Suppl. Fig. 7b). When adult zebrafish were fed different Mg2+ diets for 3 weeks, arl15b 
expression patterns reflected compensatory mechanisms to cope with Mg2+ deficiency 
(kidney and gills) or Mg2+ surplus (gut) (Suppl. Fig. 7c-e). 
 A loss-of-function approach using morpholinos (MOs) against arl15b in zebrafish 
larvae, where arl15b is expressed in the pronephros (Suppl. Fig. 8), was used to relate 
ARL15 function to renal Mg2+ wasting. Since intestinal Mg2+ absorption does not take place 
during the time frame where the knockdown is applied, a change in zebrafish larvae Mg 
content reflects a change in the renal and/or skin (renal-like tissue 36) uptake of Mg2+. Total 
Mg2+ content decreased consistently in arl15b morphants compared with controls, indicating 
renal Mg2+ wasting since the pronephric kidney is the only extrusion route for Mg2+ (Fig. 4a-
b). In parallel, cardiovascular impairments and morphological phenotypes characterized by a 
poorly metabolized yolk in comparison with controls, indicative of metabolic disturbances, 
were also observed (Fig. 4c-g). Co-injection of arl15b-MO with human WT ARL15 cRNA 
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induced a rescue of all phenotypes observed, whereas co-injection with T46N ARL15 cRNA 
did not result in any rescue (Fig. 4h-k). These rescue experiments demonstrated the 
specificity of the renal Mg2+ wasting and metabolic defects associated to dysfunctional 
ARL15. 
 
Genetic background influences the link between uMg and metabolism phenotypes  
The functional relevance of ARL15 for Mg2+ homeostasis, as demonstrated in this study, in 
combination with the association between ARL15 and obesity and insulin biology 37 urged us 
to investigate a possible link between genetic background, renal Mg2+ handling and metabolic 
traits in general population cohorts. 
 Urinary Mg-to-creatinine ratio was associated positively with circulating fasting 
adiponectin (P < 0.001) and glucose levels (P = 0.001) as well as the presence of type 2 
diabetes (P=0.03), and negatively with body mass index (BMI) (P = 0.001), fasting 
triglycerides (P = 0.012), fasting insulin (P = 0.03), homocysteine (P < 0.001) and γ-glutamyl 
transeptidase (GGT) (P < 0.001), independently of s rum Mg2+, in CoLaus (the largest cohort 
available). In CoLaus, the positive associations with adiponectin and fasting glucose, as well 
as the negative associations with BMI, GGT and homocystein, remained significant (P < 
0.05) upon adjustment for all the other metabolic phenotypes.  In SKIPOGH, 24-h uMg 
excretion was negatively associated with fasting serum insulin (P < 0.001), even after 
adjustment for the all other metabolic covariates (P = 0.003). The negative associations of 24-
h uMg excretion with fasting triglycerides or glucose disappeared upon adjustment for fasting 
insulin; we found no association of 24-h uMg excretion with BMI nor with fat mass (P > 
0.40).  
In CoLaus, the negative association of the ARL15 rs35929 variant with uMg excretion 
was stronger in overweight people (P = 0.005 for interaction between BMI and rs35929 for 
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their effect on uMg concentration in spot urine), in people with high fat mass (P interaction = 
0.024) (Fig. 5a), and in people with high fasting insulin levels (P interaction = 0.012) (Fig. 
5b), highlighting a SNP-by-environment interaction. In SKIPOGH, the negative association 
of daytime uMg excretion with fasting insulin was stronger in carriers of the ARL15 rs35929 
A allele (P interaction = 0.035), which is consistent with results in CoLaus in that rs35929 
appears to modify the association between uMG excretion and fasting insulin. The 
corresponding P values for interaction were 0.140 and 0.143 when replacing fasting insulin 
by BMI or fat mass, respectively. 
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DISCUSSION 
In this multi-step study (Fig. 6), we conducted the first genome-wide meta-analysis for uMg 
levels using data from seven population-based studies of European descent. We identified 
two genome-wide significant loci associated with uMg-to-creatinine ratio: i) rs3824347 
located on chromosome 9, near the TRPM6 gene coding for a Mg2+ channel; ii) rs35929 
located on chromosome 5, an intronic variant of the ARL15 gene known for its association 
with adiponectin 38 and lipid levels 39, 40, type 2 diabetes 40, fasting insulin levels 41 and 
coronary heart disease 38, but without a prior physiological link to Mg2+ homeostasis. Using a 
multi-level approach, we provide robust evidence that ARL15 influences renal Mg2+ 
reabsorption through regulation of the Mg2+ channel TRPM6. An additive genetic score 
including the rs35929 A (ARL15) and rs3824347 G (TRPM6) alleles is strongly associated 
with 24-h uMg2+ excretion, a physiological test of Mg2+ status, which integrates both 
intestinal absorption and renal wasting 42. In addition, the association of ARL15 rs35929 with 
uMg levels is modified by the metabolic status, and the association of uMg excretion with 
metabolic phenotypes is modified by ARL15 rs35929 in the general adult population. 
Altogether, these findings suggest a gene-diet interaction relating Mg2+ homeostasis to 
metabolic disorders in the general population. If replicated in independent populations, the 
observed genetic effect sizes are sufficiently large to be of clinical and public health 
relevance.   
 In contrast to TRPM6, little is known about the function of the ARL15 gene, except its 
association with adiponectin and lipid levels, type 2 diabetes and higher fasting insulin levels 
in humans 38-40, 43. We found that ARL15 is highly expressed in the TAL and DCT, where 
Mg2+ reabsorption is mostly regulated and where the main bulk of Mg2+ is reabsorbed. 
Particularly, we show that ARL15 is enriched along with the well-characterized Mg2+ 
channel TRPM6 in the DCT, and that ARL15 increases TRPM6-mediated currents in renal 
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epithelial cells. Since TRPM6 is the gatekeeper in transepithelial Mg2+ transport, its 
regulation by ARL15 supports a key role of the latter in the transepithelial Mg2+ transport in 
the distal part of the nephron. ARL15 is structurally similar to Ras-related GTP-binding 
proteins, which regulate intracellular vesicle trafficking 44. It interacts with proteins of the 
RAB11 and ARFGEF families, which are also involved in endocytic traffic, suggesting that 
ARL15 regulates the trafficking of vesicular TRPM6 to the plasma membrane, thereby 
influencing Mg2+ reabsorption in the kidney. In this sense, our in vivo data substantiated 
ARL15 as a key protein for the maintenance of Mg2+ homeostasis. This conclusion is 
supported by the high sensitivity of ARL15 expression to dietary Mg2+ , as demonstrated by 
the regulation of the highly conserved zebrafish ortholog of ARL15, arl15b, in the gut, kidney 
and gills of fish exposed to different Mg2+ diets – as it was already observed for the zebrafish 
ortholog of TRPM6 45. Conversely, Arl15 expression in intestine and kidney remained 
unchanged in mice fed different Mg2+ diets. This discrepancy between the mouse and the 
zebrafish model might be due to that in zebrafish, and freshwater fish in general, active 
transcellular Mg2+ reabsorption is more prominent than in terrestrial vertebrates, as 
freshwater fish are hyperosmotic respect to the surrounding aquatic medium 46, 47. Thus, the 
dietary Mg2+ challenge performed with mice in the present study is not sufficiently severe to 
evoke regulation of Arl15 expression.       
 The association of the ARL15 rs35929 variant with uMg excretion in the present 
GWAS predicted a physiological relevance of ARL15 in Mg2+ homeostasis. In agreement 
with these findings, knockdown experiments in the zebrafish recognized ARL15 as a relevant 
key protein that determines renal Mg2+ excretion. In agreement with previous GWAS linking 
ARL15 variants with risk of congestive heart disease 38, cardiovascular impairments, i.e. 
deficient tail blood circulation, was recognized in zebrafish arl15b morphants. Furthermore, 
previous links between ARL15 and lipid metabolism 37-39, 43 were functionally supported in 
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zebrafish where arl15b morphants showed a poor mobilization of yolk metabolite reserves. In 
zebrafish larvae, the yolk serves mainly as a lipid store 48, 49, therefore the deficiency in yolk 
absorption observed in arl15b morphants revealed poor lipid mobilization. The zebrafish 
arl15b morphants also accumulated fluid in the pericardial cavity and in the pronephros in the 
form of cysts showing kidney dysfunction. However, when lowering the intensity of the 
arl15b-knockdown (by using doses of 1 and 2 ng exon 4 skipping arl15b-MO/embryo), renal 
Mg2+ wasting was the only phenotype observed in the fish morphants. Therefore, the 
disturbances in Mg2+ balance observed in arl15b morphants are a primary effect of Arl15b 
dysfunction and not a secondary disturbance to the kidney/metabolic/cardiovascular 
phenotypes observed. The phenotype rescue experiments performed with normal or mutant 
versions of human ARL15 confirmed that renal Mg2+ wasting and metabolic defects were 
directly due to ARL15 knockdown. Altogether, the ARL15 functions unraveled in the present 
study illustrate an unprecedented case of shared pathophysiological genetics of renal Mg2+ 
wasting, cardiovascular disease and metabolic disorders, and demonstrate the pleiotropic 
nature of ARL15, that was inferred from the present and published GWAS. The importance 
of ARL15 is also supported by recent genetic evidence for its positive selection among 
adaptive loci identified in cattle 50. Thus far, no mutations in ARL15 have been associated 
with a monogenic disorder, including unidentified forms of renal Mg2+ wasting (Data not 
shown). 
Could the metabolic traits linked to ARL15 variants be connected? By integrating 
intestinal absorption and renal wasting, uMg2+ excretion represents a physiological test of 
Mg2+ status, more suitable than total serum Mg2+ levels 42. Urinary Mg-to-creatinine ratio was 
associated with multiple metabolic phenotypes, independently of serum Mg2+, in the 
population-based CoLaus study, providing novel insights into the metabolic consequences of 
Mg2+ deficiencies. Our results are in line with longitudinal studies in humans suggesting that 
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self-reported dietary Mg2+ intake may protect against type 2 diabetes, insulin resistance 51 and 
metabolic syndrome 52. Growing experimental evidence in favor of a beneficial role of Mg2+ 
intake on type 2 diabetes is accumulating in humans. Mg2+ supplements were found to 
significantly improve glucose tolerance and insulin sensitivity in diabetic and non-diabetic 
people 53. Whether such benefit would persist over years is currently unknown. The public 
health relevance of dietary Mg2+ intake is further underscored by an association with all-
cause mortality and risk of cardiovascular disease 51. The novelty of our results is that we 
benefit from an objective measure of Mg2+ intake, namely uMg excretion, which, unlike 
circulating Mg2+, was found to be associated with the risk of ischemic heart disease 54.  
 In population-based studies, the association between uMg and metabolic phenotypes 
(i.e. BMI, fat mass, fasting insulin levels) tended to differ by ARL15 rs35929 variants. These 
results are in line with human studies showing that Mg2+ intake exerts more protective effects 
on type 2 diabetes in overweight compared to non-overweight people 3. Such gene-diet 
interaction has already been observed for type 2 diabetes, for which the increased risk 
conferred by the rs7903146 TCF7L2 genotype was only observed in the absence of lifestyle 
intervention 55. Therefore, the ARL15 gene may modulate the beneficial effect of Mg2+ intake 
on insulin resistance in humans, offering a novel paradigm in nutrigenetics. Furthermore, the 
beneficial effect of high Mg2+ intake on metabolic disorders, such as type 2 diabetes and 
obesity, may not be uniform across individuals. 
 In conclusion, the translational data described in this study (Fig. 6) offer novel 
insights for the understanding of Mg2+ homeostasis and its relation with metabolic 
phenotypes, and identify ARL15 as a key and central player for these processes. 
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CONCISE METHODS  
Genome-wide meta-analyses  
Seven European population-based cohorts with Caucasian ethnicity (CoLaus, CROATIA-Vis, 
CROATIA-Korcula, CROATIA-Split, Lothian Birth Cohort 1936, INGI-Val Borbera, INGI-
Carlantino, described in the Supplementary Information) participated in the study, with a total 
of 9,099 individuals. A variety of electrolytes including Mg2+ as well as creatinine, were 
measured in both urine and serum (methods and mean values described in the Supplementary 
Information). 
 All cohorts were whole genome genotyped before imputation using HapMap CEU 
panel as reference (Supplementary Information). Serum Mg2+ measurements and FEMg were 
subjected to quantile-quantile normalization in order to reach normality prior to performing 
linear regression. Urinary Mg2+  measurements expressed in mg/dl were first standardized to 
urinary creatinine, then corrected for age, sex and study specific covariates (such as ancestry 
principal components, study center…) before undergoing a quantile-quantile normalization. 
The approximately 2.5M SNPs passing quality control checks were subjected to a linear 
regression of the residuals for each phenotype, and association summary statistics were 
collected. 
 Even though quantile-quantile plots of the individual GWAS showed minimal 
inflation, ruling out the presence of population substructure, a genomic-control (GC) 
correction based on the lambda factor was applied to the association P values. Subsequently, 
a meta-analysis was conducted using the inverse variant weighting method implemented in 
METAL 56. A new GC correction was applied to combined statistics. 
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SKIPOGH cohort 
SKIPOGH is a population-based family-based multicentric study focusing on blood pressure 
regulation and renal function 57. Each participant collected 24-h urine. The study was 
approved by the institutional ethical committees of each participating university hospital and 
participants signed written informed consent. 
 
VEGAS analysis  
The SNP association P values from the meta-analysis of uMg were analysed using VEGAS 
30,  a program for performing gene-based tests for association using the summary statistics 
from genetic association studies. VEGAS assigns SNPs to genes and combines their 
association P values into a gene-based test statistic. Permutations are used to calculate the 
null distribution of the test statistic for each gene in order to derive an empirical gene-wise P 
value. The gene-based approach also reduces the multiple-testing problem of GWAS by only 
considering statistical tests for 17,787 genes giving a Bonferroni-corrected threshold of P < 
2.8E−6. 
 
Pathway analysis  
We used Magenta 58 to check enrichment for pathways in either the BIOCARTA KEGG 
REACTOME databases which were contained in the msigdb version 4.0 
(http://www.broadinstitute.org/gsea/msigdb/collections.jsp#C2).  
 
Metabolome analysis  
Nuclear magnetic resonance spectroscopy data obtained from urine samples was binned and 
normalized to produce metabolome features 59. These features were then associated with the 
Page 18 of 94
ScholarOne support: 888-503-1050
Journal of the American Society of NEPHROLOGY
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
For Peer Review
18 
 
SNPs of interest, including relevant covariates among standard covariates (age, sex, genotype 
principal components) and lifestyle factors (smoking, caffeine use, dietary intake, etc.). 
 
CNV analysis  
In house datasets have been used to call CNVs and to check their correlation with the SNPs 
of interest. The CNVs call has been done using pennCNV software 60. A SNP by sample 
matrix with the copy number status has been created. Then the square correlation (Pearson’s 
correlation) between value of each SNP of interest and the SNPs copy number status in a +/- 
100 kb region has been calculated. For the SNPs of interest for which no correspondence has 
been found in the datasets, they have been replaced by the closest SNPs in high linkage 
disequilibrium (LD) and present in the datasets. LD between the SNPs of interest and a list of 
SNPs tagging CNVs from the Genetic Investigation of ANthropometric Traits (GIANT) 
consortium has also been calculated. The SNPs from the GIANT list are in LD higher than 
0.8 with their corresponding CNV 60. 
 
Laboratory measurements  
Electrolytes, haematology parameters and glycaemia were dosed in the biochemical platform 
of the University of Zürich using standard clinical laboratory methods. Creatinine was 
measured using Jaffe kinetic compensated method (Roche Diagnostics, Switzerland, intra-
assay variability 0.7-2.9%). The Chronic Kidney Disease Epidemiology Collaboration (CKD-
EPI) formula was used to calculate the estimated glomerular filtration rate (eGFR). In 
CoLaus, urinary uromodulin, creatinine, electrolytes and osmolality concentrations were 
measured in morning spot urine samples. 
 All urinary biochemical parameters were measured from samples stored at -80°C, 
using the same biochemical platform UniCel® DxC 800 Synchron® Clinical System 
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(Beckman Coulter, Nyon, Switzerland) at the University of Zürich. Appropriate controls and 
sets of calibration standards were used before running each sample batch. All cohorts were 
subjected to the same measurement protocol, in the same laboratory. 
 
Tissue distribution and localization of ARL15  
The tissue distribution of ARL15 and of its highly conserved zebrafish ortholog arl15b was 
studied in adult mouse, adult zebrafish and zebrafish larvae, as described in the 
Supplementary Information. Segmental expression of ARL15 in the mouse (C57BL/6J) 
kidney was studied at both protein and mRNA level. Five-µm sections of fixed frozen kidney 
samples were co-stained for ARL15 and specific segment markers: breast cancer resistance 
protein (BCRP) for the proximal tubule (PT), TH for the TAL, NCC for the DCT, and 
aquaporin-2 (AQP2) for the collecting duct (CD). For mRNA expression, kidneys were 
dissected and minced, before isolation of well-characterized nephron segments. For more 
details of the immunohistochemistry, micro-dissection studies and mRNA analyses in the 
nephron segments, see the Supplementary Information. 
 
 Functional studies in cells and animal models 
To study the regulation of TRPM6 channel activity by ARL15, human embryonic kidney 293 
(HEK293) cells were transfected with 1 µg of human TRPM6 cDNA 33 and 250 ng of empty 
vector (mock), human WT ARL15 or a human dominant negative (T46N) ARL15 mutant as 
negative control. Whole-cell patch clamp recordings were performed to determine the 
electrophysiological properties of the cells transfected with the constructs mentioned above 
(see details in the Supplementary Information).   
 The regulation of ARL15 gene expression by dietary Mg2+ was studied in C57BL/6J 
mice and Tupfel long-fin zebrafish (details in the Supplementary Information). These studies 
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were followed by a loss-of-function approach in zebrafish larvae using two non-overlapping 
splice-site blocking morpholinos (MOs): 5'-AAACACTGAAAGACGGGACAAAGAC-3' 
and 5'-GTTAAGCGAGTATTAGGTTACCTCT-3' (Gene Tools, Philomath, OR, USA), 
designated as exon skipping 3 and 4 arl15b-MO respectively. These antisense 
oligonucleotides were used to knockdown the highly conserved ARL15 ortholog in the 
zebrafish, arl15b. Phenotype rescue experiments were performed by co-injecting arl15b-
MOs with human ARL15 cRNA as previously described 61 and detailed in the Supplementary 
Information. The use of two non-overlapping arl15b-MOs and the combination with rescue 
experiments with human ARL15 cRNA served to rule out potential off-target effects in our 
knockdown approach.   
 
Statistical analyses in experiments performed in cellular and animal models 
All results are depicted as mean ± standard error of the mean (SEM). Statistical analyses were 
conducted by one-way ANOVA followed by the Tukey’s multiple comparison post-test. 
When only two experimental groups were affected by the factor of variance, an unpaired 
Student's t-test was used. Statistical significance was set at P ˂ 0.05. 
 
Metabolic factors associated with uMg excretion  
We used multiple linear regression to explore the association between square-root-
transformed uMg-to-creatinine ratio in spot urine and several metabolic markers (i.e. fasting 
triglycerides, total cholesterol, HDL-cholesterol, glucose, insulin, homocysteine, adiponectin, 
GGT and BMI), taken one–at–a–time as the dependent variable, while adjusting for serum 
Mg2+ and other potential confounders in SKIPOGH and CoLaus cohorts. In SKIPOGH, we 
used multivariate linear mixed effect regression to explore the association of fasting insulin 
with 24-h uMg excretion, while adjusting for potential confounders. We used a conservative 
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P value (0.05/9=0.0056) threshold to consider the associations of urinary Mg with metabolic 
phenotypes as statistically significant. 
 
SNP-by-environment interaction on uMg levels  
We explored the role of metabolic phenotypes on the association of ARL15 rs35929 with 
uMg levels in spot urine among CoLaus participants. We conducted multiple linear 
regression to explore the modifying effect of BMI, fat mass and fasting insulin levels on the 
association of the ARL15 rs35929 with square-root transformed uMg concentration, while 
including age, sex, height, lean mass, CKD-EPI, urinary creatinine (square-root), serum 
Mg2+, serum and urine Ca2+ (square-root) and menopausal status. The  P values for 
interaction were not corrected for multiple testing, as we tested a single global hypothesis 
(“does the association between rs35929 and urinary Mg differ by metabolic status?”) guided 
by prior knowledge. 
 
Note: The datasets and summary statistics are available in the IUMSP Research Data 
Repository, under the link https://data.iumsp.ch/index.php/catalog/6. 
ID Number: CHE-GWAS-V01. Created on July 12, 2017. 
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Table 1: Summary statistics for the meta-analysis of uMg-to-creatinine ratio. 
SNP Effect allele Other allele 
Mean effect 
allele 
frequency 
Effect size 
discovery 
(SE) 
p-value 
discovery 
Effect size 
replication 
(SE) 
p-value 
replication 
Effect size 
Combined 
analysis 
(SE) 
p-value 
combined 
analysis 
Direction of 
effects of 
individual 
cohorts 
I^2 
rs35929 a g 0.21 
-0.112 
5.57×10
-6
 
-0.135 
5.95×10
-7
 
-0.1227 
2.11×10
-11
 -----+- 35.7 
(-0.025) (-0.027) (-0.183) 
rs3824347 g a 0.41 
-0.109 
3.61×10
-8
 
-0.1125 
2.02×10
-6
 
-0.1103 
4.38×10
-13
 +++++++ 7 
(-0.02) (-0.024) (-0.152) 
 
The effect size sign for each individual cohort on the last but one column is represented by the sign – or +. The cohort displaying a “-” 
for rs32929 is LBC1936, having anyhow an effect close to 0. The last column shows the I^2 value, representing the heterogeneity 
across cohorts. 
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LEGENDS TO FIGURES 
Figure 1. Genome-wide meta-analysis results for uMg-to–creatinin Urinary Mg-to-
creatinine ratio. 
(a) Manhattan plot showing -log10(P values) for all SNPs in the genome-wide meta-analysis for 
normalized uMg-to-creatinine ratio in Europeans (n = 9,099), ordered by chromosomal position. 
The values correspond to the association of normalized uMg-to-creatinine ratio, including age 
and sex as covariates in the model as well as study-specific covariates if needed. The gene 
closest to the SNP with the lowest P value is listed at each locus. Two loci reached genome-wide 
significance (P < 5×10-8) at combined analysis (TRPM6, rs3824347 and ARL15, rs35929). (b) 
Forest plot for rs35929 (ARL15) and rs3824347 (TRPM6) showing effect sizes and 95% 
confidence intervals across studies as well as the summary meta-analysis results. (c) Regional 
association plot at the rs3824347 (TRPM6) locus. Regional association plot showing -log10 P 
values for the association of SNPs at the locus of interest ordered by their chromosomal position 
with normalized uMg-to-creatinine ratio. The -log10 P value for each SNP is colored according 
to the correlation of the corresponding SNP with the SNP showing the lowest P value (index 
SNP) within the locus using different colors for selected levels of linkage disequilibrium (r2). 
Correlation structures correspond to HapMap 2 CEU. The blue line represents the recombination 
according to the scale shown on the right-side Y axis. (d) Regional association plot at the 
rs35929 (ARL15) locus. See Panel b legend. 
 
Figure 2. External population-based validation using 24-h urine data. 
(a-d) Associations of uMg excretion and fractional excretion with an unweighted genetic risk 
score including rs35929 (ARL15 locus) and rs3824347 (TRPM6 locus). Data are geometric 
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means and whiskers are 95% confidence intervals for Mg-related phenotypes in the CoLaus 
(panels a,b,d) and SKIPOGH (panel c) studies. The X axes represent the unweighted genetic 
score generated from rs35929 (ARL15 locus) and rs3824347 (TRPM6 locus), using as effect 
allele the one associated with lower uMg-to-creatinine ratio, i.e. the A allele for rs35929 and the 
G allele for rs3824347. P values are from non-parametric trend tests across genetic score. The 
numbers in each genetic score category are listed in all panels. The Y axis represents uMg-to-
creatinine ratio (mg/g) (a), FEMg (%) (b), uMg excretion (mg/24h) (c) and serum Mg2+ (mg/dl) 
(d).  
 
Figure 3. ARL15 localizes in renal DCT regulating TRPM6 channel activity.  
(a) Gene expression analyses of Trpm6, Arl15, Podocin, Sglt2, Snat3, Nkcc2, Ncc and Aqp2 in 
micro-dissected mouse nephron segments showed co-expression of Arl15 and Trpm6 in DCT. 
(b) Double immunofluorescence staining of mouse kidney cortex sections for ARL15 (in green) 
and BCRP (red); TH (red); NCC (red); or AQP2 (red) as markers of the PT, TAL, DCT or CD 
respectively. (c) Typical current-voltage curves obtained from transfected HEK293 cells 200 s 
after break-in. Outwardly-rectifying currents are observed in r sponse to a 500 ms voltage ramp 
(from -100 to +100 mV) applied 200 s after break-in. (d) The average time development of the 
current density measured at +80 mV is shown (n ≥ 10). The mock + ARL15 condition is not 
shown for clarity reasons. (e) WT ARL15 (red, WT, n = 47) but not the T46N ARL15 mutant 
(black, T46N, n = 18) increased the whole-cell current density of TRPM6. Asterisks indicate 
significant differences respect to the cells transfected with TRPM6 only (blue, ‘-‘, n = 44). One-
way ANOVA followed by Tukey’s multiple comparisons post-test, P ˂ 0.05. (f) Transfection of 
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HEK293 cells with WT ARL15 did not evoke a significant increase in whole-cell current density 
when compared with mock-transfected of cells  (n ≥ 10, unpaired Student's t-test).   
 
Figure 4. Physiological relevance of ARL15 in kidney.   
(a-b) Knockdown of arl15b by 0.5-2 (a) and 2-8 (b) ng/embryo of the two arl15b-MOs used 
(exon skipping 3 and 4 arl15b-MOs) resulted in a dose-dependent decrease of the total Mg 
content of zebrafish arl15b morphants, reflecting renal Mg2+ wasting. The zero dose represents 
injection with control-MO (2 (a) and 8 (b) ng MO/embryo). (c) Morphological phenotypes 
distinguished in zebrafish larvae (5 days post-fertilization (dpf)) following treatment with 
arl15b-MO or control-MO. A complete description of each phenotype is detailed in the 
Supplementary Information. Metabolic defects (poor metabolization of the yolk) are indicated by 
arrows. (d-g) Distribution of morphological phenotypes in zebrafish larvae injected with 0.5-2 
(d, f) and 2-8 (e, g) ng/embryo of exon skipping 3 (d, e), exon skipping 4 (f, g) arl15b-MO or 
control-MO (2 (d, f) and 8 (e, g) ng MO/embryo). (h-k) Rescue of renal Mg2+ wasting (h, j) and 
of metabolism defects (i, k) in morphant zebrafish by co-injection of exon skipping 3 arl15b-MO 
(0.5 ng MO/embryo, h-i) or exon skipping 4 arl15b-MO (8 ng MO/embryo, j-k) with cRNA 
encoding human WT ARL15 (50 pg cRNA/embryo). Co-injection with cRNA encoding human 
T46N ARL15 mutant (50 pg cRNA/embryo) did not rescue renal Mg2+ wasting or the defects in 
metabolism. (d-g, i, k) Numbers on top of the bars indicate the number of animals in each 
experiment. (a-b, h, j) Data are presented as mean ± SEM (n = 10, except for b, where n = 6-10). 
(a-b, h, j) Asterisks indicate significant differences respect to the control condition (One-way 
ANOVA followed by Tukey’s multiple comparisons post-test, P ˂ 0.05). 
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 Figure 5. Effect modification of metabolic phenotypes on the association of uMg with the 
ARL15 locus. 
(a) Effect modification of fat mass on the association of uMg concentration with rs35929 
(ARL15) genotypes. Data represent adjusted square-root transformed uMg levels by rs35929 
genotypes and fat mass strata in CoLaus. The model was adjusted for age, sex, height, lean mass, 
CKD-EPI, urinary creatinine (square-root), serum Mg2+, serum and urinary Ca2+ (square-root) 
and menopausal status. P interaction = 0.024. Fat mass strata are cut by sex-specific medians. n 
= 4,729. (b) Effect modification of fasting insulin on the association of uMg levels with rs35929 
(ARL15) genotypes. Data represent adjusted square-root transformed uMg levels by rs35929 
genotypes and fasting insulin strata in CoLaus. The model was adjusted for age, sex, height, lean 
mass, CKD-EPI, urinary creatinine (square-root), serum Mg2+, serum and urinary Ca2+ (square-
root) and menopausal status. P interaction = 0.012. Fat mass strata are cut by sex-specific 
medians (n = 4,729). 
 
Figure 6. Multi-step approach used to investigate the genetic determinants of the renal 
handling of Mg
2+
 and their influence on metabolic traits in the general population. 
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SUPPLEMENTARY METHODS  
GWAS Cohorts  
CoLaus is a population-based cohort with baseline examination conducted between 2003 and 
2006. It includes 6,184 individuals of European descent aged 35-75 years randomly selected 
from the registry of the city of Lausanne 1. The CROATIA-Vis study, Croatia, is a family-
based, cross-sectional study in the isolated island of Vis that included 1,056 examinees aged 
18-93. Blood samples were collected in 2003 and 2004 2.  The CROATIA-Korcula study, 
Croatia, is a family-based, cross-sectional study in the isolated island of Korcula that included 
965 examinees aged 18-95. Blood samples were collected in 2007 3. The CROATIA-Split 
study, Croatia, is population-based, cross-sectional study in the Dalmatian city of Split that so 
far includes 1,012 examinees aged 18-95. Blood samples were collected in 2009 -2011 4. The 
Lothian Birth Cohort 1936 (LBC1936) consists of 1,091 relatively healthy older participants, 
most of whom took part in the Scottish Mental Survey of 1947 at the age of about 11 years. 
At a mean age of 69.5 years (SD 0.8) they were recruited to a study investigating influences 
on cognitive ageing 5. A second wave of cognitive and physical testing occurred at 
approximately 73 years of age at which time a urine sample was collected 5, 6. The INGI-Val 
Borbera population is a collection of 1,785 genotyped samples (18-102 years) collected in the 
Val Borbera Valley, a geographically isolated valley located within the Appennine Mountains 
in Northwest Italy 7. The INGI-Carlantino study is a population-based, cross-sectional study 
in a village situated in the Southeastern part of the Apennines in a hilly area of the Puglia 
region. Main study characteristics are summarized in Suppl. Table 4, genotyping details on 
Suppl. Table 5. 
 
Micro-dissection studies in mouse kidney  
Well-characterized tubular segments were microdissected from mouse kidneys as described 
previously 8. Kidneys from male C57BL/6J mice were dissected and minced before 
incubation with 0.1% (w/v) type 2 collagenase solution that contained 100 μg/ml soybean 
trypsin inhibitor for 30 min at 37°C. After digestion, the supernatant was sieved through 250- 
and 80-μm nylon filters. Nephron fragments remained in the 80-μm sieve and were 
resuspended by flushing. Distinct segments [glomeruli (GLOM), proximal convoluted and 
straight tubules (PCT and PST respectively), thick ascending loop of Henle (TAL), distal 
convoluted tubule (DCT) and collecting duct (CD)] were isolated upon their morphologic 
features. Three collections were snap-frozen in liquid nitrogen and conserved at -80°C. 
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Immunohistochemistry 
Nephron immunohistochemistry was performed as described previously 9, 10. In short, co-
staining for ARL15, breast cancer resistance protein (BCRP), Tamm-Horsfall protein (TH), 
thiazide sensitive Na+-Cl- cotransporter (NCC) and aquaporin-2 (AQP2) was performed on 5-
µm sections of fixed frozen mouse (C57BL/6J) kidney samples. The sections were incubated 
for 16 h at 4°C with the following primary antibodies: rabbit anti-ARL15 (1:100, Sigma 
Chemical Co., St Louis, USA), rat anti-BCRP (1:250 10), sheep anti-TH (1:750 10), rabbit anti-
NCC (1:50 11) or rabbit anti-AQP2 (1:1000, kindly provided by Dr. Deen, Nijmegen, The 
Netherlands). For detection, kidney sections were incubated with Alexa Fluor-conjugated 
secondary antibodies. Images were taken with a Zeiss Axio Imager 1 microscope 
(Oberkochen, Germany) equipped with a HXP120 Kubler Codix fluorescence lamp and a 
Zeiss Axiocam MRm digital camera.  
 
Cell culture and transfection  
Human embryonic kidney 293 (HEK293) cells were grown at 37°C in DMEM (Biowhittaker 
Europe, Vervier, Belgium) supplemented with 10% (v/v) FCS (PAA Laboratories, Linz, 
Austria), non-essential amino acids (AAs), and 2 mM L-glutamine in a humidified 5% (v/v) 
CO2 atmosphere. 
 Cells were seeded in 12-well plates and subsequently transfected with a total of 1.25 
μg of cDNA (per well in a 12 wells plate) using Lipofectamine 2000 (Invitrogen, Breda, The 
Netherlands). HA-tagged human TRPM6 was in the pCINeo-IRES-GFP mammalian 
expression vector 12. A human ARL15 clone was obtained from Source BioScience (Berlin, 
Germany) and subcloned into the pCINeo-IRES-mCherry vector, used for transfections. The 
T46N mutation was inserted in the ARL15 construct using the QuikChange site-directed 
mutagenesis kit (Stratagene, La Jolla, CA, USA) according to the manufacturer’s protocol. 
All constructs were verified by sequence analysis. Mock conditions were obtained by 
transfecting the empty pCINeo-IRES-mCherry vector. Approximately 36 h after transfection, 
cells were seeded on glass coverslips coated with 50 µg/ml fibronectin (Roche Diagnostics, 
Mannheim, Germany). Experiments were started 2 h after seeding the cells. Cells displaying 
both GFP and mCherry fluorescence were chosen for recording. 
 
Electrophysiology  
All experiments were performed at room temperature. Whole-cell recordings were undertaken 
and analyzed using an EPC-9 amplifier and the Patchmaster software (HEKA electronics, 
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Lambrecht, Germany). The sampling interval was set to 100 µs (10 kHz) with a low-pass 
filter set at 2.9 kHz. Pipettes were pulled from thin wall borosilicate glass (Harvard 
Apparatus, March-Hugstetten, Germany) and had resistance between 1 and 3 MΩ when filled 
with the pipette solution. Series resistance compensation was set to 75-95% in all 
experiments. Currents were elicited by a series of 500 ms voltage ramps (from -100 to +100 
mV) applied every two seconds from a holding voltage of 0 mV. Current densities were 
obtained by normalizing the current amplitude to the cell capacitance.  
 The extracellular solution contained (in mM): 150 NaCl, 1 CaCl2, 10 HEPES and pH 
adjusted to 7.4 using NaOH. The pipette solution was made of (in mM): 150 NaCl, 10 
Na2EDTA, 10 HEPES and pH adjusted to 7.2 using NaOH. 
 
Conservation of ARL15 proteins  
TBLASTN searches were performed on the mouse, cow and zebrafish genome database at 
NCBI (http://blast.ncbi.nlm.nih.gov/Blast.cgi) using the human ARL15 as query AA 
sequence. Sequences with a significant homology with human ARL15 were selected. Multiple 
sequence alignments were carried out using ClustalW (http://www.ebi.ac.uk/Tools/clustalw/) 
and the degree of AA conservation across species was discerned. 
 
Distribution of Arl15 gene expression and dietary Mg2+ challenge in mice  
To study the tissue distribution of Arl15 gene expression, three C57BL/6J mice were 
sacrificed; lung, bone, kidney, peritoneum, stomach, brain, heart, liver and muscle tissues 
were collected. The dietary Mg2+ challenge was performed on age- and gender-matched 
C57BL/6J wild type (WT) littermates. Mice were housed in a temperature- and light-
controlled room with ad libitum access to standard pellet chow (SSNIFF Spezialdiäten, Soest, 
Germany) and deionized drinking water for 4 weeks until the start of the experiment. Three 
groups of mice were next fed a control diet (0.19% (w/w) Mg; n = 10), a Mg²+-deficient diet 
(0.0005% (w/w) Mg; n = 10), or a Mg²+-enriched diet (0.48% (w/w) Mg; n = 10) (SSNIFF 
Spezialdiäten, Soest, Germany) for 10 days. Mice were housed individually in metabolic 
cages overnight at baseline, day 5 and day 10 for urine collection (16 h sampling). Venous 
blood samples were obtained from the inferior vena cava during sacrifice at day 10, and 
kidneys and intestine (ileum and caecum) were harvested as previously described 13. All 
protocols were conducted in accordance with the National Research Council Guide for the 
Care and Use of Laboratory animals and were approved by the local Ethics Committee. 
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Distribution of arl15b gene expression and dietary Mg2+ challenge in zebrafish  
Zebrafish from the Tupfel long-fin (TLF) strain were used for experimentation. For the study 
of the tissue distribution of the highly conserved ARL15 zebrafish ortholog (arl15b) in adult 
zebrafish tissues, 3 females and 3 males were dissected following anaesthesia (0.1% (v/v) 2-
phenoxyethanol (Sigma Chemical Co., St Louis, USA)) and brain, ovary, gills, testis, heart, 
spleen, kidney, gut, operculum, scales and liver tissues were collected and stored at -80°C 
until analysis. In 5 days post-fertilization (dpf) larvae, animals were anaesthetised with 
tricaine/Tris pH 7.0 solution and pronephric tissue was isolated with fine-point needles under 
the microscope (Leica Microsystems Ltd). After removal of the yolk and swim bladder, the 
pronephros could be distinguished by the pigments that surround the pronephric tubules 
(Suppl. Fig. 8). Then, pronephric-enriched tissue was scratched and subsequently aspirated 
with a Pasteur pipette. Samples were constituted by 10 pronephros each, which were stored at 
-80°C until further analysis. Control genes were used to verify the purity of the pronephric 
tissue isolated: ncc, uniquely expressed in the pronephros 14, served as positive control; and 
ncc-like, whose gene expression is restricted to the skin 15, served as negative control.   
 To study the regulation of arl15b gene expression by the Mg2+ status in zebrafish 
ionoregulatory tissues (gills, kidney and gut), fish Mg2+ balance was challenged by different 
Mg2+ diets as previously reported 16. Briefly, 27 adult zebrafish were weighed and randomly 
divided into 3 groups of 9 animals each and kept in 3 separate 2-liter tanks. During 2 weeks 
(acclimation to control conditions), all fish were fed a Mg2+-control diet (Hope Farms, 
Woerden, The Netherlands; 0.07% (w/w) Mg) at a daily ration of 2% (w/w) of the total body 
weight. After this period, for 2 groups, the control diet was replaced by a Mg2+-deficient diet 
(Hope Farms; 0.01% (w/w) Mg) or a Mg2+-enriched diet (Hope Farms; 0.7% (w/w) Mg). 
These 2 groups were kept under these feeding regimes for 3 weeks, while the remaining group 
(fed a Mg2+-control diet) served as a control. At the end of this period, all groups were 
sampled. Sampling took place 24 h after the last feeding. Fish were anaesthetised in 0.1% 
(v/v) 2-phenoxyethanol (Sigma). After anaesthesia, death of animals was induced by spinal 
transaction and organs were collected, immediately frozen in liquid nitrogen and stored at -
80°C until analysis. All animal procedures detailed here were performed in accordance with 
national and international legislation and were approved by the ethical review committee of 
the Radboud University Nijmegen. 
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Knockdown of the zebrafish ortholog of human ARL15 and rescue experiments  
WT TLF zebrafish were bred and raised under standard conditions (28.5°C and 14 h of light: 
10 h of dark cycle) in accordance with international and institutional guidelines. Zebrafish 
eggs were obtained from natural spawning. The following splice-site blocking morpholinos 
(MOs) were designed to knockdown arl15b expression: 5'-
AAACACTGAAAGACGGGACAAAGAC-3' and GTTAAGCGAGTATTAGGTTACCTCT-
3' (Gene Tools, Philomath, OR, USA), designated as exon 3 and 4 skipping arl15b-MO 
respectively. A standard mismatch MO, directed against a human β-globin intron mutation, 5'-
CCTCTTACCTCAGTTACAATTTATA-3', was also used in the experiments to control for 
toxic effects of the MO molecule. MOs were diluted in deionized, sterile water supplemented 
with 0.5% (w/v) phenol red and injected in a volume of 1 nl into the yolk of one- to two-cell 
stage embryos using a Pneumatic PicoPump pv280 (World Precision Instruments, Sarasota, 
FL, USA). WT embryos (uninjected) were also included in the experiments to control for the 
effects of the injection procedure per se. To determine the most effective dose of the arl15b-
MO, 0.5, 1 and 2 ng arl15b-MO; and 2, 4 and 8 ng arl15b-MO were injected in two sets of 
experiments. In these experiments, control embryos were injected with 2 or 8 ng of the 
standard mismatch control-MO (the highest dose for each set of experiments respectively). 
After injection, embryos from the same experimental condition were placed in 3 Petri dishes 
and cultured at 28.5°C in E3 embryo medium (5 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 
0.33 mM MgSO4), which was refreshed daily.  
 Morphological phenotypes characterizing kidney function and yolk metabolization 
were analyzed in larvae at 5 dpf. Larvae were classified into different classes of phenotypes 
on the basis of comparisons with stage-matched control embryos (injected with the control-
MO) of the same clutch. In arl15b morphant larvae (5 dpf), 4 different phenotypes were 
distinguished: normal; mild, larvae with mild-moderate pericardial edema (indicative of 
kidney dysfunction) and metabolic defects (poor metabolization of the yolk); moderate, 
moderate pericardial edema accompanied by kidney cysts in approximately 75% of the cases, 
metabolic defects (poor metabolization of the yolk) and cardiovascular defects (poor blood 
circulation in the tail); severe, severe pericardial edema accompanied by kidney cysts in 
approximately 80% of the cases, metabolic defects (poor metabolization of the yolk) and 
cardiovascular defects (poor blood circulation or absence in the tail and severe bradychardia 
(heart beat rate below 100 beats per minute)). Representative images were obtained with a 
DFC450C camera (Leica Microsystems Ltd) after anaesthetising larvae with tricaine/Tris pH 
7.0 solution.  
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 For electrolyte measurements or RNA isolation, 7-10 zebrafish larvae were pooled as 
one sample. Samples were then snap frozen in liquid nitrogen and stored at -80°C in order to 
ensure euthanasia of animals. 
 In vivo cRNA rescue experiments were performed with human WT ARL15 and 
dominant negative mutant (T46N) ARL15 cRNAs. Constructs were sub-cloned into the 
pT7Ts expression vector, suitable for rescue experiments in zebrafish 17, and cRNAs were 
prepared using the mMESSAGE mMACHINE Kit (Ambion, Austin, TX, USA) according to 
the manufacturer's instructions. The cRNAs, in an amount of 50 pg, as based on previous 
studies 18, 19, were (co)injected together with MOs as described above. Zebrafish larvae were 
phenotyped at 5 dpf.  
 
Electrolyte measurements in animal studies  
In mice, urinary creatinine and electrolytes as well as plasma urea and creatinine (enzymatic 
determination) were measured on a Synchron Unicel DxC 800 analyzer (Beckman Coulter, 
Brea, USA). In zebrafish, sample processing started by washing twice the samples with 
nanopure water in order to avoid contamination of remaining waterborne Mg2+. Fish were 
then dried and digested as described previously 19. The total Mg content in each sample was 
determined with a colorimetric assay (Roche). Within-run precision and accuracy was 
controlled by means of an internal control Precinorm (CV = 0.8%). Furthermore, samples 
were normalized by protein content, which was determined with the Pierce BCA protein assay 
kit (Pierce Biotechnology, Rockford, IL, USA). 
 
RNA isolation and cDNA synthesis  
In mouse, total RNA was extracted from different tissues using the AurumTM Total RNA 
Fatty and Fibrous Tissue Kit (Bio-Rad, Hercules, CA), following the manufacturer’s protocol. 
In zebrafish, RNA was isolated from zebrafish tissues and larvae using TRIzol reagent 
(Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions in which 
glycogen (Fermentas GmbH, St. Leon-Rot, Germany) was used in order to maximize the 
RNA recovery. This method allowed the isolation of more than 3 µg RNA per tissue or 
whole-larvae sample (n = 7-10 larvae/sample), and of more than 200 ng RNA per pronephric 
samples (10 pronephros/sample). In both, mouse and zebrafish RNA samples, one µg of 
RNA, or 200 ng in the case of pronephric samples, was subjected to DNase treatment to 
prevent genomic DNA contamination and subsequently used to perform the reverse 
transcriptase reaction. 
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Reverse transcription quantitative polymerase chain reaction (RT-qPCR)  
Changes in target genes mRNA levels were determined by relative RT-qPCR following the 
MIQUE guidelines 20 with a CFX96TM Real-Time PCR Detection System (Bio-Rad 
Laboratories, Hercules, CA) using iQTM SYBR Green Supermix (Bio-Rad) detection of single 
PCR product accumulation. To study the effect of dietary Mg2+ on gene expression in mouse 
kidney, ileum and caecum, the geNorm algorithm was used with 5 reference genes to 
calculate the normalization factor (software geNorm version 3.4). The reference genes used 
encoded for β-actin (Actb), glyceraldehyde 3-phosphate dehydrogenase (Gapdh), 
peptidylprolyl isomerase A (Ppia), attachment region binding protein (Arbp) and 
hypoxanthine phosphoribosyltransferase 1 (Hprt1). In the rest of procedures with mice (tissue 
distribution and gene expression profile in different mouse nephron segments) and in the 
zebrafish studies, gene expression levels were normalized to the expression levels of the 
standard species-specific reference genes Gapdh (for mice 21, 22) and elongation factor-1α 
(elf1α, for zebrafish 16, 23). Here, relative mRNA expression was analysed using the Livak 
method (2-ΔΔCt). Primer sequences are shown in Suppl. Table 8. 
 
Efficacy of the splice-site blocking arl15b-morpholinos. To determine the efficacy of the 
splice blocking induced by the exon 3 skipping arl15b-MO, cDNA from 5 dpf control 
(injected with 0.5 ng control-MO) and morphant (injected with 0.5 ng arl15b-MO) larvae was 
used for PCR analysis. The primers used were 5'- CGAGGTCACAGGGGTGTTTC-3' as 
forward primer and 5'- GACGAAGCGCTGTCCAAAAC-3' as reverse primer. Fragments 
thus obtained were extracted from a 1.5% agarose gel and Sanger-sequenced (Suppl. Fig. 9) to 
confirm the splice blocking induced. 
In the case of the exon 4 skipping arl15b-MO, cDNA was generated from fish injected with 2 
ng control or arl15b-MO. Primers used were 5'- CTGACGGGTTCTGGGAAGAC-3' as 
forward primer and 5'- ACCGTGCTTCCCTCTAGGAT-3' as reverse primer. Given the 
absence of a spliced-arl15b transcript in 2-5 dpf fish (as a result of nonsense-mediated decay 
of arl15b mRNA by the exon 4 skipping arl15b-MO, Suppl. Fig. 10), the efficacy of the 
approach was further studied by RT-qPCR using specific primers that discriminate for the 
functional (non-spliced) arl15b transcript: the forward primer targets the exon 3-4 junction 
and the reverse primer targets exon 4 (Suppl. Table 8). 
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SUPPLEMENTARY FIGURES 
Supplementary Figure 1. Manhattan plot from the GWAS on uMg-to-creatinine ratio 
for the CoLaus cohort. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Manhattan plot showing -log10(P values) for all SNPs in the genome-wide association for 
normalized uMg-to-creatinine ratio in CoLaus (n=5,150), ordered by chromosomal position. 
The values correspond to the association of normalized uMg-to-creatinine ratio, including as 
covariates age, sex and the first principal components generated from all genotypes to take 
population structure into account. One locus (TRPM6) reached genome-wide significance (P 
< 5×10-8). 
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Supplementary Figure 2. QQ plot and conditional analyses for the uMg-to-creatinine 
ratio. 
(a) QQ plot from the meta-analysis of uMg-to-creatinine ratio. 
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(b) Zoom plot showing the TRPM6 region’s associations to uMg-to-creatinine ratio after 
conditioning the analysis for rs3824347. 
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(c) Zoom plot showing the ARL15 region’s associations to uMg-to-creatinine ratio after 
conditioning the analysis for rs35929.  
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Supplementary Figure 3. Manhattan plot from the GWAS on serum Mg2+ levels for the 
meta-analysis. 
. 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Manhattan plot showing all –log10(P values) for the combined analysis of the GWAS on 
serum Mg2+, ordered by chromosome position. A locus on chromosome one reaches genome-
wide significance. (b) Regional association plot of the region on chromosome one identified 
on the Manhattan plot on panel A. It shows a gene-rich locus, with no obvious candidate for 
being the gene involved. 
a 
b 
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Supplementary Figure 4. Manhattan plot from the meta-analysis of fractional excretion 
of Mg2+ (FEMg) GWASs. 
 
 
Manhattan plot showing all –log10(P values) for the combined analysis of the GWAS on 
FEMg, ordered by chromosome position. No signal reaches genome-wide significance. 
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Supplementary Figure 5. Functional protein association network analyses for ARL15. 
 
 
ARL15 interacts with regulators of endocytic (RAB11FIP4, UBC) and vesicular (ARFGEF1) 
trafficking, factors involved in maintenance of cell polarity (ARFGEF1), factors influencing 
sodium handling (KNG1) and regulators of ubiquitination (UBC).  
(http://string-db.org/cgi/network.pl?taskId=NPTdrqbgkFZS). Network nodes represent 
proteins, whereas different colored nodes refer to different proteins. Small nodes (MON2) 
refer to proteins of unknown 3D structure while large nodes represent proteins whose 3D 
structure is known or predicted (ARL15, KNG1, NUMBL, RAB11FIP3, RAB11FIP4, 
ARFGEF1, ARFGEF2, UBC, NUMB, FBXO8). Edges represent protein-protein associations: 
blue, interactions from curated databases (e.g. UBC-NUMB); magenta, experimentally 
determined interactions (e.g. ARL15-ARFGEF1, ARL15-ARFGEF2, ARL15-UBC, ARL15-
MON2, ARL15-FBXO8); green, interactions derived from text mining (e.g. ARL15-
RAB11FIP3, ARL15-RAB11FIP4, ARL15-NUMBL, ARL15-KNG1, ARL15-NUMB); 
purple, interactions deduced by protein homology (e.g. ARFGEF1-ARFGEF2). 
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Supplementary Figure 6. Tissue distribution of Arl15 gene expression in mouse tissues 
and regulation of gene expression by dietary Mg2+ in mouse tissues relevant for Mg2+ 
handling. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Tissue distribution of Arl15 gene expression in mouse tissues. Relative gene expression in 
mouse tissues and organs was analysed using the Livak method (2−ΔΔCt), where results are 
normalized against the reference genes Gapdh and expressed relative (%) to the gene 
expression in the kidney, chosen as calibrator. Data are presented as mean ± SEM (n = 3). (b-
d) Gene expression levels of Trpm6, parvalbumin (Pvalb), Arl15, the Na+-Cl- cotransporter 
(Ncc), calbindin D-28k (Cabd28), the calcium-sensing receptor (Casr) and the Na+-K+-Cl- 
cotransporter isoform 2 (Nkcc2) in mouse kidney (b); of Trpm6, Arl15, the zinc transporter 10 
(Slc30a10) and the alpha subunit of the epithelial sodium channel (Alpha Enac) in mouse 
ileum (c); and Trpm6, Arl15, Slc30a10 and Alpha Enac in mouse caecum (d). Mice were fed a 
control diet (0.19% (w/w) Mg), a Mg²+-deficient diet (0.0005% (w/w) Mg), or a Mg²+-
enriched diet (0.48% (w/w) Mg) for 10 days. Gene expression data were calculated using the 
geNorm algorithm and represent the mean fold difference (mean ± SEM, n = 10 for kidney 
and n = 5 for ileum and caecum) from the control group (mice on the control diet). *P < 0.05 
compared with the control group. 
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Supplementary Figure 7. The zebrafish Arl15b protein is a highly conserved ortholog of 
human ARL15 being its gene expression is magnesiotropic in kidney, gills and gut. 
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(a) Alignment of the human, mouse and cow ARL15 proteins (GenBank accession no. 
NP_061960, NP_766183 and NP_001014943 respectively) and zebrafish Arl15 paralogs: 
Arl15a and Arl15b (GenBank accession no. NP_001093503 and XP_001923547 
respectively). Identical AA are boxed in black, conservative substitutions in gray. Sequence 
identity of zebrafish Arl15a with human, mouse and cow ARL15 is 68, 66 and 67% 
respectively. Zebrafish Arl15b displayed a strikingly high degree of AA conservation with its 
mammalian counterparts: 83, 81 and 79% with human, mouse and cow ARL15 respectively. 
(b) Tissue distribution of arl15b gene expression in zebrafish tissues. Relative gene 
expression in mouse and zebrafish tissues and organs was analysed using the Livak method 
(2−ΔΔCt), where results are normalized against the translational elf1α and expressed relative 
(%) to the gene expression in the brain, chosen as calibrator. Data are presented as mean ± 
SEM ( n = 6, except for the ovary and testis where n = 3). (c-e) Gene expression levels of 
arl15b in kidney (c), gills (d) and gut (e) of zebrafish on a Mg2+-deficient diet (0.01% (w/w) 
Mg), Mg2+-control diet (0.07% (w/w) Mg) and Mg2+-enriched diet (0.7% (w/w) Mg) for 21 
days. Data were calculated using the Livak method (2-ΔΔCt) and they represent the mean fold 
difference (mean ± SEM, n = 8-9) from the control group (fish on the control diet). *P < 0.05 
was considered statistically significant when compared with the control group. 
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Supplementary Figure 8. The arl15b gene is expressed in the pronephric kidney of 
zebrafish larvae. 
 
 
 
 
 
 
(a) The pronephros of 5 dpf zebrafish larva after dissection for collection of pronephric-
enriched tissue. Pronephric tubules can be distinguished by the black pigments that develop 
around the tubuli. (b) Gene expression of arl15b and the control genes ncc (uniquely 
expressed in the pronephros, as positive control) and ncc-like (distinctly expressed in the skin, 
as negative control) in the pronephros and total larvae. Relative gene expression was analysed 
using the Livak method (2−ΔΔCt), where r sults are normalized against the reference gene elf1α 
and expressed relative (%) to the gene expression in total larvae. Data are presented as mean ± 
SEM (n = 3). 
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Supplementary Figure 9. Efficacy of the exon 3 skipping arl15b-MO used. 
 
 
 
 
 
 
 
 
 
 
 
(a) Expected PCR products using forward (FW) and reverse (RV) primers located in exon 1 
and 4 respectively on arl15b mRNA with normal splicing or altered splicing evoked by the 
arl15b-MO. (b) Gel electrophoresis image showing defects in the splicing process following 
injection of arl15b-MO (morphants, dose of 0.5 ng arl15b-MO/embryo) or control-MO 
(controls, dose of 0.5 ng control-MO/embryo). Bands showing correctly spliced arl15b 
mRNA and MO-spliced arl15b mRNA are shown. PCR was performed on cDNA prepared 
from larvae 5 days after injection. Shown on the left are the sizes (in bp) of the major bands of 
the DNA ladder. The expected amplicon size of the correctly spliced arl15b mRNA and the 
MO-spliced arl15b mRNA using FW and RV primers is of 411 bp and 351 bp respectively. 
(c) Chromatograms obtained from Sanger sequencing of the amplicons in the correctly spliced 
arl15b mRNA and the MO-spliced arl15b mRNA. The arl15b-MO evoked exon 3 skipping 
yielding a knockdown of Arl15b function. By skipping exon 3 with the arl15b-MO, the 
resulting protein lacks active domains such as the complete switch I region and part of the 
switch II region (switch regions are surface loops that undergo conformational changes upon 
GTP binding) and G3 box. 
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Supplementary Figure 10. Efficacy of the exon 4 skipping arl15b-MO used. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) Expected PCR products using forward (FW) and reverse (RV) primers located in exon 2 
and 5 respectively on arl15b mRNA with normal splicing or altered splicing evoked by the 
arl15b-MO. (b) Gel electrophoresis image showing knockdown of arl15b gene expression 
following injection of arl15b-MO (morphants, dose of 2 ng arl15b-MO/embryo) or control-
MO (controls, dose of 2 ng control-MO/embryo) in 2-5 dpf zebrafish larvae. Bands showing 
correctly spliced arl15b mRNA are shown, while bands showing MO-spliced arl15b mRNA 
could not be detected so that the exon 4 skipping arl15b-MO evoked nonsense-mediated 
decay of arl15b transcripts. Shown on the left are the sizes (in bp) of the major bands of the 
DNA ladder. The expected amplicon size of the correctly spliced arl15b mRNA and the MO-
spliced arl15b mRNA (not detected) using FW and RV primers is of 413 bp and 204 bp 
respectively. (c-f) Characterization of the knockdown evoked by injection of 2 ng of exon 4 
skipping arl15b-MO. Controls were injected with 2 ng of control-MO. C, total Mg content in 
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5 dpf morphant and control zebrafish larvae. Data are presented as mean ± SEM (n = 10). *P 
< 0.05 was considered statistically significant when compared with the control group. (d) 
Quantification of the knockdown evoked by the exon 4 skipping arl15b-MO by RT-qPCR 
using specific primers that discriminate for the correctly spliced (functional) arl15b mRNA. 
Data were calculated using the Livak method (2-ΔΔCt) and they represent the mean fold 
difference (mean ± SEM, n = 10) from the control group (fish injected with the control-MO). 
*P < 0.05 was considered statistically significant when compared with the control group. (e) 
Distribution of morphological phenotypes in the zebrafish larvae (5 dpf) used for the 
quantification of the arl15b knockdown by RT-qPCR. Numbers on top of the bars indicate the 
number of animals in each experimental condition. (f) Illustrative picture showing the 
characteristic phenotype (normal) evoked by knockdown of arl15b (2 ng/embryo of exon 4 
skipping arl15b-MO). 
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SUPPLEMENTARY TABLES  
Supplementary Table 1. Summary statistics for the genome-wide meta-analysis of serum Mg2+ levels. 
 
 Effect 
allele 
Other 
allele 
Mean 
effect allele 
frequency 
Effect size 
discovery 
(SE) 
P value 
discovery 
Effect 
size 
replica 
(SE) 
P value 
replica 
Effect size 
combined 
analysis 
(SE) 
P value 
combined 
analysis 
Direction of 
effects of 
individual 
cohorts 
 
I^2 
rs4460629 T C 0.56 -0.144 
(0.02) 
4.89 x10-13 -0.100 
(0.04) 
 
1.15 
x10-2 
-0.136 
(0.018) 
4.45 x10-14 --?- 14.6 
 
The effect size sign for each individual cohort on the last but one column is represented by the sign – or +. The cohort displaying a “?” is for the 
Carlantino cohort, not having data for rs4460629. The last column shows the I^2 value, representing the heterogeneity across cohorts. 
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Supplementary Table 2. Imputation status and quality for rs35929 and rs3824347. 
 
SNP COLAUS CARLANTINO KORCULA LBC1936 SPLIT 
VAL 
BORBERA VIS 
rs35929 I(0.95) I (0.81) I (1) I(1) I(1) I(1) I(1) 
rs3824347 I(0.97) I(0.76) I(0.95) I(0.97) I(0.98) I(0.97) I(0.98) 
 
Imputation status (G= genotyped, I=imputed) for both SNPs of interest in each cohort. Between brackets is the r2 value representing imputation 
quality. 
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Supplementary Table 3. Association of ARL15 variants with metabolic phenotypes. 
Source Trait SNP 
p-value of 
association 
in published 
GWAS 
Chr Position Gene Region Context PubMed 
reference 
allele 
p-value for 
uMg/uCreat 
in Meta-
analysis 
Beta for 
uMg/uCreat 
in Meta-
analysis 
Standard 
error of 
Beta for 
uMg/uCreat 
in Meta-
analysis  
dbGaP Body 
Weight 
rs2042313 2.45x10-7 5 53212417 ARL15 Intron 17903300 NA NA NA NA 
dbGaP Body 
Weight 
rs2042313 5.15x10-7 5 53212417 ARL15 Intron 17903300 NA NA NA NA 
NHGRI 
GWAS 
Catalog 
Adiponectin rs6450176 6.00x10-8 5 53298025 ARL15 Intron 22479202 a 0.59 0.0091 0.0169 
NHGRI 
GWAS 
Catalog 
Cholesterol, 
HDL 
rs6450176 5.00x10-8 5 53298025 ARL15 Intron 20686565 a 0.59 0.0091 0.0169 
NHGRI 
GWAS 
Catalog 
Adiponectin rs4311394 3.00x10-8 5 53300662 ARL15 Intron 20011104 a 0.63 -0.0079 0.0165 
dbGaP Uric Acid rs10513040 3.55x10-6 5 53502295 ARL15 Intron 17903292 a 0.052 -0.0663 0.0341 
 
Summary of previously associated SNPs in ARL15 in published GWAS. The SNP associated with body weight is not present in our study. The 3 
other SNPs are not significantly associated in the present uMg-to-creatinine meta-analysis, as shown in the last 3 columns. 
Data were exported from dbGAP browser: http://www.ncbi.nlm.nih.gov/gap.  
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Supplementary Table 4. Study characteristics. 
Study CoLaus INGI-Val Borbera INGI-Carlantino CROATIA-Vis CROATIA-Korcula CROATIA-Split LBC1936 
Sample size 5265 1541 281 195 889 489 660 
Female % (N) 53% 56% 56.80% 58% 63.80% 56.50% 47.90% 
Age, years mean (SD) 53.4 (10.7) 55 (18) 48 (19.7) 56.36 (15.5) 56.3 (13.9) 49.25 (14.7) 72.74 (0.75) 
Serum Mg (mg/dl) mean (SD) 2.06 (0.166) 2.2 (0.3) 2.1 (0.2) NA 2.04 (0.21) NA NA 
Serum creatinine (mg/dl) mean (SD) 1.05 (0.24) 0.87 (0.25) 0.8 (0.2) 0.99 (0.32) 0.92 (0.18) 0.93 (0.15) NA 
Urine Mg (mg/dl) mean (SD) 6.9 (4.0) 8.4 (4.8) 8.1 (5) 5.93 (4.52) 7.6 (4) 8.76 (4.9) 8.70 (5.61) 
Urine creatinine (mg/dl) mean (SD) 161.9 (81.4) 105.4 (59.1) 80.5 (42.1) 103.18 (65.8) 133.8 (63.8) 154.72 (72.98) 115.75 (62.20) 
Urine Mg/creat ratio (mg/gr) mean (SD) 46.51 (25.98) 88.6 (36.5) 104.6 (44.8) 62.55 (33.37) 63.7 (32.5) 60.6 (26.8) 82.03 (42.23) 
FEMg  mean (SD) 3.27 (1.65) 5.2 (2.5) 6.0 (2.6) NA 2.55 (1.33) NA NA 
eGFR (mean, SD) 89.39 (20.03) 89.23 (23.28) NA 89.41 (21.18) 87.72 (21.16) 94.92 (23.34) NA 
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Supplementary Table 5. Study genotyping characteristics. 
Study CoLaus INGI-Val Borbera INGI-
Carlantino 
CROATIA-Vis CROATIA-
Korcula 
CROATIA-Split LBC1936 
Array type Affymetrix 
500K 
Illumina 370k Illumina 370k Illumina 
HumanHap300v1
Illumina 
HumanHap370CNV
Illumina 
HumanHap370CNV 
Illumina 610 
Genotype 
calling 
BRLMM BeadStudio analysis 
software 
BeadStudio 
analysis software 
Genome Studio Genome Studio Genome Studio Genome studio 
QC filters for 
genotyped 
SNPs used 
for 
imputation 
pHWE<1e-7; 
individual call 
rate <90%; 
SNP call 
rate<70%; 
MAF<0.01 
call rate >= 90%; 
MAF >= 1%; pHWE p 
> 0.0001 
call rate >= 90%; 
MAF >= 1%; 
pHWE p > 
0.0001 
SNP Call 
rate<=0.98, 
MAF<0..01, 
pHWE<1e-6, 
Individual Call 
rate<0.95 
SNP Call 
rate<=0.98, 
MAF<0..01, 
pHWE<1e-6, 
Individual Call 
rate<0.95 
SNP Call 
rate<=0.98, 
MAF<0..01, 
pHWE<1e-6, 
Individual Call 
rate<0.95 
pHWE<p < 1x10-3  
individual call rate 
<95%; SNP call 
rate<98%; MAF<0.01 
No of SNPs 
used for 
imputation 
390'631 332'887 309’430 289'827 
 
307'625 
 
321'456 
 
~500,000 
Imputation IMPUTE v0.2 MACH MACH MACH 1.0.16 MACH 1.0.16 MACH 1.0.16 MACH 
Imputation 
Backbone for 
phased CEU 
haplotypes 
(NCBI build) 
HapMap 
release 21 
(build 35) 
HapMap release 22 
(build 36) 
HapMap release 
22 (build 36) 
 
HapMap release 
22 (build 36) 
 
HapMap release 22 
(build 36) 
 
HapMap release 22 
(build 36) 
 
HapMap II (build 36) 
Filtering of 
imputed 
genotypes 
None Rsq>0.3 Rsq>0.3 
 
None None None none 
Data 
management 
and statistical 
QUICKTEST R, GenABEL, 
ProbABEL (mmscore 
function was used to 
R, GenABEL, 
ProbABEL 
(mmscore 
R, GenABEL, 
ProbABEL 
(mmscore 
R, GenABEL, 
ProbABEL 
(mmscore function 
R, GenABEL, 
ProbABEL 
(mmscore function 
mach2qtl 
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analysis account for 
relatedness) 
function was 
used to account 
for relatedness) 
function was 
used to account 
for relatedness) 
was used to account 
for relatedness) 
was used to account 
for relatedness) 
Population 
stratification 
or Principal 
Components 
We included 
the first 3 
principal 
components as 
covariates 
We included the first 3 
principal components 
as covariates 
We included the 
first 3 principal 
components as 
covariates 
We included the 
first 3 principal 
components as 
covariates 
We included the 
first 3 principal 
components as 
covariates 
We included the first 
3 principal 
components as 
covariates 
We included the first 4 
principal components as 
covariates 
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Supplementary Table 6. Urine (U) parameters in mice fed different Mg2+-containing diets. 
Baseline 
 
Control diet 
(n=10) 
Mg2+ deficient diet 
(n= 11) 
Mg2+ excess diet 
(n=10) 
Body weight (g) 23.7 ± 0.4 23.9 ± 0.8 25.6 ± 0.4* 
Diuresis (µl/16h) 1307 ± 162 1467 ± 244 1985 ± 285 
Diuresis (µl/min.gBW) 0.058 ± 0.007 0.066 ± 0.012 0.080 ± 0.012 
U Na+ (nmol/min) 164 ± 16 170 ± 19 177 ± 15 
U K+ (nmol/min) 413 ± 40 479 ± 42 501 ± 46 
U Cl- (nmol/min) 229 ± 21 263 ± 29 265 ± 26 
U Mg²+ (nmol/min) 586 ± 59 621 ± 54 656 ± 78 
 
Day 5  Control diet 
(n=10) 
Mg2+ deficient diet 
(n= 11) 
Mg2+ excess diet 
(n=10) 
Body weight (g) 24.3 ± 0.5 24.3 ± 0.8 25.8 ± 0.5* 
Diuresis (µl/16h) 1064 ± 49 1390 ± 168 1126 ± 132≠ 
Diuresis (µl/min.gBW) 0.046 ± 0.002 0.060 ± 0.01 0.045 ± 0.005≠ 
U Na+ (nmol/min) 156 ± 14 171 ± 20 123 ± 20 
U K+ (nmol/min) 382 ± 36 393 ± 45 327 ± 52≠ 
U Cl- (nmol/min) 210 ± 20 239 ± 28 168 ± 30≠ 
U Mg²+ (nmol/min) 478 ± 42 13 ± 3*,≠ 1269 ± 184*,≠ 
 
Day 10 Control diet 
(n=10) 
Mg2+ deficient diet 
(n= 11) 
Mg2+ excess diet 
(n=10) 
Body weight (g) 24.1 ± 0.4 24.3 ± 0.9 25.9 ± 0.5* 
Diuresis (µl/16h) 1516 ± 136§ 1447 ± 149 1334 ± 124≠ 
Diuresis (µl/min.gBW) 0.066 ± 0.006§ 0.062 ± 0.005 0.053 ± 0.005≠ 
U Na+ (nmol/min) 189 ± 16§ 176 ± 23 140 ± 18 
U K+ (nmol/min) 532 ± 46§ 465 ± 43 409 ± 51 
U Cl- (nmol/min) 287 ± 26≠,§ 263 ± 33 195 ± 28*,≠ 
U Mg²+ (nmol/min) 723 ± 49§ 8.1 ± 1.7*,≠,§ 1399 ± 149*,≠ 
*P  < 0.05 versus control diet; ≠ P < 0.05 versus baseline; § P < 0.05 versus day 5 
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Supplementary Table 7. Plasma (P) parameters in mice fed different Mg2+-containing diets. 
Day 10 Control diet 
(n=10) 
Mg2+ deficient diet 
(n= 11) 
Mg2+ excess diet 
(n=10) 
Body weight (g) 23.4 ± 0.5 23.3 ± 0.8 24.5 ± 0.6 
P urea (mg/dl) 51.4 ± 1 64.7 ± 3.9* 52.0 ± 2.6≠ 
P creatinine (mg/dl) 0.07 ± 0.01 0.07 ± 0.01 0.08 ± 0.01 
P Na+ (mmol/l) 154 ± 1 157 ± 1* 152 ± 1*,≠ 
P K+ (mmol/l) 4.0 ± 0.2 4.4 ± 0.1* 4.7 ± 0.2* 
P Cl- (mmol/l) 110 ± 1 111 ± 1 108 ± 1 
P Ca2+ (mmol/l) 2.26 ± 0.03 2.06 ± 0.03* 2.29 ± 0.03≠ 
P Mg2+ (mg/dl) 2.95 ± 0.10 1.08 ± 0.11* 3.13 ± 0.13≠ 
*P  < 0.05 versus control diet; ≠ P < 0.05 versus Mg2+ deficient diet 
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Supplementary Table 8. Primer oligonucleotide sequences used in the present study during RT-qPCR measurements. 
 Primer sequence 5’ → 3’ Species Amplicon size 
(bp) 
Efficiency (%) 
Actb  Mouse 102 102 
Forward TGCCCATCTATGAGGGCTAC    
Reverse CCCGTTCAGTCAGGATCTTC    
Arl15  Mouse 133 98 
Forward TCATCAAGACAAGCCAGCAG    
Reverse GCTGTCCTTCAGTGTGTCCA    
Gapdh  Mouse 176 104 
Forward TGCACCACCAACTGCTTAGC    
Reverse GGATGCAGGGATGGGGGAGA    
Podocin  Mouse 162 103 
Forward GTCTAGCCCATGTGTCCAAA    
Reverse CCACTTTGATGCCCCAAATA    
Pvalb  Mouse 136 97 
Forward GACGCCATTCTTCTGGAAAT    
Reverse ATACCCCCACTGCCCTAAAA    
Arbp  Mouse 150 99 
Forward CTTCATTGTGGGAGCAGACA    
Reverse TTCTCCAGAGCTGGGTTGTT    
Ncc  Mouse 148 101 
Forward CATGGTCTCCTTTGCCAACT    
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Reverse TGCCAAAGAAGCTACCATCA    
Nkcc2  Mouse 154 99 
Forward CCGTGGCCTACATAGGTGTT    
Reverse GGCTCGTGTTGACATCTTGA    
Aqp2  Mouse 147 103 
Forward TCACTGGGTCTTCTGGATCG    
Reverse CGTTCCTCCCAGTCAGTGT    
Ppia  Mouse 139 102 
Forward CGTCTCCTTCGAGCTGTTTG    
Reverse CCACCCTGGCACATGAATC    
Hprt1  Mouse 162 99 
Forward ACATTGTGGCCCTCTGTGTG    
Reverse TTATGTCCCCCGTTGACTGA    
Sglt2  Mouse 164 101 
Forward TTGGGCATCACCATGATTTA    
Reverse GCTCCCAGGTATTTGTCGAA    
Trpm6  Mouse 156 100 
Forward CACAAGCCAGTGACCACCTA    
Reverse GAGGCTCTTGAGGGCTTTTT    
Snat3  Mouse 109 99 
Forward GTTATCTTCGCCCCCAACAT    
Reverse TGGGCATGATTCGGAAGTAG    
Alpha Enac  Mouse 151 96 
Forward CCTGGGCAGCTTCATCTTTA    
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Reverse GACTCCAGGCATGGAAGACA    
Casr  Mouse 150 97 
Foward CTCTGCTGCTTCTCCAGCT    
Reverse GGCCTCAAATACCAGGAGGA    
Cabd28  Mouse 154 101 
Forward CTGACAGAGATGGCCAGGTT    
Reverse AGCAAAGCATCCAGCTCATT    
arl15b  Zebrafish 133 104 
Forward AAGGAACTCGGAGGAGCAGACTCA    
Reverse AGTGGAGCTCTGTACGCGCC    
elf1α  Zebrafish 89 100 
Forward GAGGCCAGCTCAAACATGGGC    
Reverse AGGGCATCAAGAAGAGTAGTACCGC    
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